newsfilter
← Latest News
PR Newswire·

Sanofi to acquire Principia Biopharma

Sanofi and Principia Biopharma Inc. (NASDAQ: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated...